A new study published in the September 2011 issue of the American Journal of Infection Control (vol. 39 No. 7 pps 555-559) has confirmed that soft-surface textiles are significant sources of bacterial contamination in healthcare settings, with 63 percent of physician and nurse uniforms testing positive for pathogenic organisms, including those that are multi-drug resistant (11 percent). The study was conducted by the Shaare Zedek Medical Center in Jerusalem. It looked at 238 samples from 135 of their hospital personnel [60 (45 percent) physicians and 75 (55 percent) nurses].
The study also cited the lack of standardized protocols for laundering of uniforms. Forty percent of participants laundered their uniforms at home and just 58 percent reported changing the uniform every day. Furthermore, the rate of contamination with resistant pathogens was higher in attire changed every two days compared with that changed every day (29 percent versus 8 percent).
According to Joel Furey, president of Noble Biomaterials Healthcare Division, This study further underscores the need for healthcare settings to do all they can to minimize and eliminate patient risk of contamination including creating and enforcing standardized guidelines for laundering. Todays healthcare bacterial management practices focus on hand hygiene and hard surface sanitization. Fabrics made with X-STATIC® silver fibers, have an antimicrobial fiber technology clinically-proven to reduce 99.9 percent of bacteria and add a critical dimension to infection control efforts not currently being employed.Â
Soft-surface textiles account for 90 percent of the healthcare patient environment and include patient gowns, privacy curtains and bed linens. Of the 238 samples obtained in the study, 119 (50 percent) were positive for any pathogen most with one pathogen (94 cultures; 79 percent of the positive cultures) and fewer with two or three different pathogens (21 [18 percent] and 4 [3 percent] of the positive cultures, respectively). There were no significant differences between the gowns worn by physicians and nurses. Potentially pathogenic bacteria were isolated from at least one site of the gowns in 85 of the 135 participants (63 percent).
X-STATIC® antimicrobial technology is designed to provide a simple and cost-effective method for hospitals to deliver a proven bacterial management solution for soft surface textile materials. X-STATIC® fibers are permanently bonded with a layer of 99.9 percent pure metallic silver, which creates an ionic shield that inhibits the growth of bacteria and fungi for the life of the product. This decreases the overall level of bacterial contamination, which would have the potential to transmit to the patient. X-STATIC technology is clinically-proven to reduce 99.9 percent of bacteria directly on the fabric in healthcare settings. For more information visit www.InfectionPreventionTextiles.com.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.